Rep. Crenshaw: Innovation, Not Pelosi's Radical Price Controls, Will Lower Drug Costs
February 27, 2020
February 27, 2020
WASHINGTON, Feb. 27 -- Rep. Dan Crenshaw, R-Texas, issued the following news release:
Congressman Dan Crenshaw (TX-02) penned an op-ed in the Houston Chronicle highlighting the need to lower drug costs without crushing the innovation of new cures. Crenshaw is a co-sponsor of the Lower Costs, More Cures Act (H.R. 19), a bipartisan bill that would lower the cost of specialty drugs while ensuring innovation continues to thrive, and bad actors are removed from the system.
H . . .
Congressman Dan Crenshaw (TX-02) penned an op-ed in the Houston Chronicle highlighting the need to lower drug costs without crushing the innovation of new cures. Crenshaw is a co-sponsor of the Lower Costs, More Cures Act (H.R. 19), a bipartisan bill that would lower the cost of specialty drugs while ensuring innovation continues to thrive, and bad actors are removed from the system.
H . . .